Published in Can J Infect Dis on July 01, 1997
A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med (1977) 11.49
Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun (1982) 9.97
Catheter complications in total parenteral nutrition. A prospective study of 200 consecutive patients. N Engl J Med (1974) 4.89
Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol (1985) 3.14
Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med (1971) 3.14
Risk of local and systemic infection with polyethylene intravenous catheters. A prospective study of 213 catheterizations. N Engl J Med (1968) 3.00
Intravenous catheters and infection. Surg Clin North Am (1972) 2.47
Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery (1982) 2.22
Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med (1987) 2.03
Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak. J Antimicrob Chemother (1988) 2.00
Predictive value of surveillance skin cultures in total-parenteral-nutrition-related infection. Lancet (1982) 1.92
In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (1985) 1.84
Infectious complications of indwelling vascular catheters. Clin Infect Dis (1992) 1.77
Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1986) 1.75
A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis (1989) 1.75
The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med (1991) 1.69
Subclavian vein catheterizations: a prospective study. II. Infectious complications. Ann Surg (1971) 1.63
Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA (1992) 1.57
Septic complications of total parenteral nutrition. A five year experience. Am J Surg (1976) 1.42
A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med (1981) 1.34
Pathogenesis and predictability of central venous catheter sepsis. Surgery (1982) 1.33
Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN J Parenter Enteral Nutr (1985) 1.32
Etiology of catheter-associated sepsis. Correlation with thrombogenicity. Arch Surg (1977) 1.29
Application of antibiotic ointment to the site of venous catheterization--a controlled trial. J Infect Dis (1969) 1.17
Microbial colonization of indwelling central venous catheters: statistical evaluation of potential contaminating factors. Am J Surg (1979) 1.15
Risk of infection with intravenous indwelling catheters: effect of application of antibiotic ointment. J Infect Dis (1969) 1.11
Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent. J Antimicrob Chemother (1987) 1.09
Relatedness of tetracycline resistance plasmids among species of coagulase-negative staphylococci. Antimicrob Agents Chemother (1985) 1.08
Infections caused by aterial catheters used for hemodynamic monitoring. Am J Med (1979) 1.03
Colonization of central venous catheters. South Med J (1984) 1.02
The natural history of intravenous catheter-associated phlebitis. Arch Intern Med (1984) 1.01
Mupirocin: a topical antibiotic with a unique structure and mechanism of action. Clin Pharm (1987) 0.93
Intravenous feeding in a gastroenterological unit: a prospective study of infective complications. J Clin Pathol (1979) 0.92
Infectious complications of percutaneously inserted central venous catheters. Acta Anaesthesiol Scand (1985) 0.88
Mupirocin for the reduction of colonization of internal jugular cannulae--a randomized controlled trial. J Hosp Infect (1990) 0.87
Use of percutaneously inserted venous catheters in coronary care units. Chest (1972) 0.86
Subclavian vein catheterization and infection. A bacteriological study of 130 catheter insertions. Scand J Infect Dis (1972) 0.84
Reduction in the colonization of central venous cannulae by mupirocin. J Hosp Infect (1991) 0.81
Risk factors associated with intravascular catheter infections in burned patients: a prospective, randomized study. J Trauma (1989) 0.79
An evaluation of triple-lumen catheter infections using a guidewire exchange technique. J Trauma (1990) 0.76
Effect of mupirocin on nasal carriage of Staphylococcus aureus. J Hosp Infect (1989) 0.76
A microbiologic investigation of percutaneous central venous catheters. South Med J (1972) 0.76
The use of subclavian central venous catheters in gynecology and obstetrics. Surg Gynecol Obstet (1973) 0.76
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med (1998) 5.33
PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol Cell (1998) 4.82
Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. Health Technol Assess (2004) 4.59
A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes. J Biol Chem (1995) 4.03
Symptom assessment in schizophrenic prodromal states. Psychiatr Q (1999) 3.09
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol (2001) 3.06
Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis (2001) 2.86
A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42. Nature (1993) 2.60
Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol (2001) 2.50
Does participating in physical activity in outdoor natural environments have a greater effect on physical and mental wellbeing than physical activity indoors? A systematic review. Environ Sci Technol (2011) 2.45
Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell Mol Life Sci (2005) 2.32
Use of a nasal continuous positive airway pressure mask in the treatment of postoperative atelectasis in aortocoronary bypass surgery. Crit Care Med (1990) 2.21
Disseminated candidiasis due to amphotericin B-resistant Candida albicans. J Infect Dis (1992) 2.01
Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb Drug Resist (2004) 1.97
The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity. J Biol Chem (2001) 1.96
Undergraduate teaching of genitourinary medicine in Britain--what are the issues? Genitourin Med (1996) 1.88
Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation. Health Technol Assess (2010) 1.80
Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest (1995) 1.75
A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis (1989) 1.75
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med (2006) 1.73
Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1989) 1.68
Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child (2000) 1.67
Pneumothorax in patients with AIDS. Respir Med (1993) 1.65
Performance of case definitions for influenza surveillance. Euro Surveill (2015) 1.62
Comparison of palmolein and olive oil: effects on plasma lipids and vitamin E in young adults. Am J Clin Nutr (1995) 1.57
The curation guidelines of the immune epitope database and analysis resource. Cytometry A (2008) 1.56
Predicting recovery of facial nerve function following injury from a basilar skull fracture. J Neurosurg (1991) 1.55
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut (1996) 1.53
Abdominal wall hernias in patients with abdominal aortic aneurysmal versus aortoiliac occlusive disease. Am J Surg (1995) 1.50
A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse. Pain (1997) 1.49
Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression. Ann Oncol (2006) 1.48
Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities. J Am Coll Cardiol (1990) 1.48
Parasitism of molluscs by nematodes: types of associations and evolutionary trends. J Nematol (2003) 1.47
Health technology assessment in primary and community care. Br J Gen Pract (2000) 1.47
Mechanism of repetitive monomorphic ventricular tachycardia. Circulation (1995) 1.47
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Health Technol Assess (2007) 1.46
Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations. Eur J Biochem (1996) 1.45
Levodopa induces dyskinesias in normal squirrel monkeys. Ann Neurol (2001) 1.44
Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS (1992) 1.43
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness. Br J Cancer (2009) 1.43
Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J Biol Chem (2001) 1.41
An algorithmic approach to the diagnosis of NK and T cell lymphomas. Pathology (2011) 1.41
Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. Genitourin Med (1997) 1.41
Involvement of Pex13p in Pex14p localization and peroxisomal targeting signal 2-dependent protein import into peroxisomes. J Cell Biol (1999) 1.41
The Drosophila CPEB homolog, orb, is required for oskar protein expression in oocytes. Dev Biol (1999) 1.39
High-protein, low-carbohydrate diets: do they work? J Am Diet Assoc (2000) 1.39
Rates and outcomes of diabetic end-stage renal disease among registered native people in Saskatchewan. CMAJ (1994) 1.38
The tyrosine kinase ACK1 associates with clathrin-coated vesicles through a binding motif shared by arrestin and other adaptors. J Biol Chem (2001) 1.35
The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model. Health Technol Assess (2009) 1.35
Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes. FEBS Lett (1994) 1.33
Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues. Parasite Immunol (2009) 1.30
Measuring desire for death among patients with HIV/AIDS: the schedule of attitudes toward hastened death. Am J Psychiatry (1999) 1.29
Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv (2005) 1.29
The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum Genet (2006) 1.27
Reliability of length measurements in full-term neonates. J Obstet Gynecol Neonatal Nurs (1998) 1.26
Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems. Health Technol Assess (2010) 1.26
Integrin expression by primary and immortalized human chondrocytes: evidence of a differential role for alpha1beta1 and alpha2beta1 integrins in mediating chondrocyte adhesion to types II and VI collagen. Osteoarthritis Cartilage (2000) 1.26
Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J Biol Chem (1997) 1.26
Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls. Neurology (2002) 1.25
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Health Technol Assess (2006) 1.21
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess (2007) 1.21
Modulation of the activities of catalase-peroxidase HPI of Escherichia coli by site-directed mutagenesis. Biochemistry (2000) 1.19
Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing. J Clin Microbiol (1998) 1.19
Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol (1992) 1.17
The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor. J Immunol (2000) 1.15
New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res (1999) 1.14
Dissolution of multicomponent microbubbles in the bloodstream: 2. Experiment. Ultrasound Med Biol (1998) 1.12
The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders. Health Technol Assess (2012) 1.12
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Health Technol Assess (2007) 1.12
An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction. Eur J Surg Oncol (2008) 1.12
Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials. Clin Invest Med (1994) 1.11
Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis. Br J Cancer (2008) 1.11
From "thrifty genotype" to "hefty fetal phenotype": the relationship between high birthweight and diabetes in Saskatchewan Registered Indians. Can J Public Health (2001) 1.10
The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol (1994) 1.10
CSF shunt complications: an analysis of contributory factors. Childs Nerv Syst (1985) 1.09
Pathways to HIV testing and care by black African and white patients in London. Sex Transm Infect (2002) 1.09
Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta. Arthritis Rheum (2000) 1.08
Evaluation of enzyme immunoassay for Candida cytoplasmic antigens in neutropenic cancer patients. J Clin Microbiol (1994) 1.08
IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J Immunol (1997) 1.07
Serological and functional properties of monoclonal antibodies to Escherichia coli type I pilus and capsular antigens. Prog Allergy (1983) 1.06
Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response. J Immunol (2000) 1.06
GABAergic excitotoxicity injury of the immature hippocampal pyramidal neurons' exposure to isoflurane. Anesth Analg (2011) 1.06
Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis. Health Technol Assess (2004) 1.05
T cell selection during the evolution of CD8+ T cell memory in vivo. Eur J Immunol (1998) 1.05
Increased TLR4 expression in murine placentas after oral infection with periodontal pathogens. Placenta (2008) 1.05
Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest (1994) 1.04
Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. J Clin Microbiol (2003) 1.04
Proteoglycan production by immortalized human chondrocyte cell lines cultured under conditions that promote expression of the differentiated phenotype. Arch Biochem Biophys (2000) 1.04
A comparison of computerized tomographic staging systems in chronic sinusitis. Clin Otolaryngol Allied Sci (1996) 1.03
Counsellors in primary care in Southampton: a questionnaire survey of their qualifications, working arrangements, and casemix. Br J Gen Pract (1997) 1.03
Treatment issues for HIV+ Africans in London. Soc Sci Med (1999) 1.02
Evidence in infants with cleft palate that breast milk protects against otitis media. Pediatrics (1994) 1.01
Isolation and primary structure of beta-endrophin and beta-lipotropin from bovine pituitary glands. Biochem Biophys Res Commun (1977) 1.01
Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study. Breast (2003) 1.01
Risk factors for hip fracture in men. Hip Fracture Study Group. Am J Epidemiol (1997) 1.01
Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. Tissue Antigens (2000) 1.00
Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression. Proc Natl Acad Sci U S A (2000) 1.00
Approach to management of the heartbeating 'brain dead' organ donor. JAMA (1989) 1.00
The cost-effectiveness of testing for hepatitis C in former injecting drug users. Health Technol Assess (2006) 1.00